What are the key clinical and laboratory findings to differentiate and identify the specific type of vasculitis in a patient?

How to Identify Which Type of Vasculitis

To identify the specific type of vasculitis, you must systematically classify by vessel size first, then use ANCA testing, biopsy, and clinical pattern recognition to narrow the diagnosis—this structured approach is essential because treatment differs dramatically between vasculitis types and delays increase morbidity and mortality.

Algorithmic Approach to Vasculitis Diagnosis

Step 1: Classify by Vessel Size (Primary Framework)

The Chapel Hill Consensus classification based on vessel caliber is your starting point 1, 2:

• Large vessel: Aorta and major branches (Giant Cell Arteritis, Takayasu Arteritis)
• Medium vessel: Main visceral arteries (Polyarteritis Nodosa, Kawasaki Disease)
• Small vessel: Arterioles, capillaries, venules (ANCA-associated vasculitis, cryoglobulinemic vasculitis)

Step 2: Perform ANCA Testing in Appropriate Clinical Context

ANCA testing (both indirect immunofluorescence AND ELISA for PR3 and MPO) should be performed when small-medium vessel vasculitis is suspected 1. This is Level 1A evidence with Grade A recommendation.

Key ANCA patterns:

• c-ANCA (PR3): Strongly suggests Granulomatosis with Polyangiitis (Wegener's)
• p-ANCA (MPO): Suggests Microscopic Polyangiitis or Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss)
• ANCA-negative: Consider Polyarteritis Nodosa, cryoglobulinemic vasculitis, or large vessel vasculitis

Step 3: Obtain Tissue Biopsy

A positive biopsy showing fibrinoid necrosis, granulomas, or pauci-immune glomerulonephritis is the gold standard and strongly recommended 1. Diagnostic yield exceeds 70% when the appropriate organ is sampled 1.

Biopsy targets based on clinical involvement:

• Kidney: For suspected glomerulonephritis
• Skin: For palpable purpura or ulcers
• Nerve: For mononeuritis multiplex
• Lung: For pulmonary infiltrates/hemorrhage
• Temporal artery: For suspected Giant Cell Arteritis

Step 4: Use Structured Clinical Assessment

At every visit, perform systematic organ-by-organ evaluation 1. The clinical pattern often distinguishes vasculitis types:

Small Vessel (ANCA-Associated):

• Granulomatosis with Polyangiitis: Upper respiratory (sinusitis, saddle nose), lower respiratory (nodules, hemorrhage), kidney (glomerulonephritis)
• Microscopic Polyangiitis: Kidney and lung predominant, NO granulomas
• Eosinophilic Granulomatosis with Polyangiitis: Asthma, eosinophilia, cardiac involvement (myocarditis—high mortality risk) 3

Medium Vessel:

• Polyarteritis Nodosa: Abdominal pain, testicular pain, mononeuritis multiplex, NO glomerulonephritis, check Hepatitis B 1
• Kawasaki Disease: Coronary arteritis in children 3

Large Vessel:

• Giant Cell Arteritis: Age >50, temporal headache, jaw claudication, vision loss, elevated ESR/CRP 4
• Takayasu Arteritis: Age <40, limb claudication, blood pressure discrepancies, vascular bruits 4

Step 5: Essential Laboratory Tests

Baseline labs for every suspected vasculitis case 1, 5:

• ESR and CRP (elevated in most, but NOT specific)
• Complete blood count (eosinophilia in EGPA)
• Serum creatinine and urinalysis (hematuria, proteinuria, RBC casts)
• ANCA (IF + ELISA for PR3/MPO)
• Complement levels (low in cryoglobulinemic vasculitis)
• Cryoglobulins
• Hepatitis B and C serology (secondary vasculitis)
• Anti-GBM antibodies (if rapidly progressive glomerulonephritis)

Step 6: Distinguish Primary from Secondary Vasculitis

Check for underlying causes:

• Infections: Hepatitis B (PAN), Hepatitis C (cryoglobulinemic vasculitis) 1
• Autoimmune diseases: Lupus, rheumatoid arthritis, Sjögren's
• Drugs: Cocaine, levamisole, hydralazine
• Malignancy: Paraneoplastic vasculitis

Critical Pitfalls to Avoid

1. Don't wait for ANCA results to start treatment in life-threatening disease: Rapidly progressive glomerulonephritis or pulmonary hemorrhage requires immediate cyclophosphamide and glucocorticoids 1

2. ANCA-negative doesn't exclude vasculitis: 10-20% of ANCA-associated vasculitis can be ANCA-negative; biopsy is essential 1

3. No specific biomarkers exist for large vessel vasculitis: Diagnosis relies on imaging (ultrasound, MRA, PET-CT) and clinical features 4, 5

4. Overlap syndromes exist: Vessel size categories aren't absolute; some vasculitides affect multiple vessel sizes 3, 2

5. Distinguish vasculitis from vasculopathy: Atherosclerosis, thromboembolism, and fibromuscular dysplasia can mimic vasculitis but require completely different treatment 3

When to Refer

All suspected primary systemic vasculitis should be managed at or in collaboration with centers of expertise 1. This is particularly critical for:

• Refractory or relapsing disease
• Uncertain diagnosis
• Need for specialized procedures (temporal artery biopsy, vascular surgery)

Imaging Considerations

For medium-large vessel vasculitis when biopsy isn't feasible 3:

• CT angiography: Luminal stenosis, aneurysms
• MR angiography: Vessel wall thickening, no radiation
• PET-CT: Active inflammation (best for large vessel)
• Doppler ultrasound: Temporal artery "halo sign" in GCA

The key is integrating vessel size classification, ANCA results, biopsy findings, and clinical pattern—no single test confirms vasculitis type, but this systematic approach maximizes diagnostic accuracy and minimizes treatment delays 1, 5, 3.